METTL3/IGF2BP2-Mediated m6A RNA Methylation Drives Alveolar Macrophage-Dependent Neutrophil Recruitment in Cigarette Smoke-Induced COPD.

阅读:4
作者:Lin Andi, Wang Jian, Wang Lixing, Zhang Yaping
INTRODUCTION: Chronic inflammatory infiltration caused by cigarette smoke is one of the primary characteristics that define chronic obstructive pulmonary disease (COPD), but the epigenetic mechanisms governing immune cell crosstalk remain poorly defined. This study aims to elucidate the critical role of m(6)A RNA methylation in modulating alveolar macrophage-neutrophil interactions during COPD progression. METHODS: A mouse COPD model was employed, combined with mechanistic studies that included pharmacological inhibition, RNA stability assay, RIP, m6A-qPCR, and cell chemotaxis assay in cells, to investigate the effect of cigarette smoke exposure on m(6)A regulatory molecules and immune cell interactions. RESULTS: Cigarette smoke exposure upregulated METTL3 and IGF2BP2 expression in alveolar macrophages. METTL3-mediated m(6)A modification promoted the stability of CXCL8 mRNA in an IGF2BP2-dependent manner, leading to enhanced CXCL8 secretion and neutrophil recruitment. Concurrently, METTL3-mediated m(6)A modification stabilized ICAM-1 mRNA in endothelial cells, facilitating neutrophil adhesion and transmigration. This dual-cell mechanism synergistically amplifies neutrophilic inflammation in COPD. DISCUSSION: Our results uncover a novel epitranscriptional pathway through which cigarette smoke promotes neutrophilic inflammation via m(6)A-dependent regulation of both CXCL8 in macrophages and ICAM-1 in endothelial cells. These findings position the METTL3/IGF2BP2/m(6)A axis as a central regulatory mechanism coordinating multicellular interactions in COPD pathogenesis and suggest its potential as a therapeutic target for modulating disease progression.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。